The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

被引:0
|
作者
Ming Shi
Dan Liu
Huijun Duan
Lu Qian
Lina Wang
Lijia Niu
Huipeng Zhang
Zheng Yong
Zehui Gong
Lun Song
Ming Yu
Meiru Hu
Qing Xia
Beifen Shen
Ning Guo
机构
[1] Institute of Basic Medical Sciences,Department of Molecular Immunology
[2] Hebei Medical University,Department of Pathology
[3] People’s Armed Police Corps Hospital,Department of the Obstetrics and Gynecology
[4] The Laboratory of Evaluation for New Drug,undefined
[5] Institute of Pharmacology and Toxicology,undefined
来源
关键词
β2-AR; Her2; STAT3; ERK; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
In this study, β2-AR level was found to be up-regulated in MCF-7 cells overexpressing Her2 (MCF-7/Her2). Correlation of β2-AR level with Her2 status was demonstrated in breast cancer tissue samples. Constitutive phosphorylation of ERK, mRNA expression up-regulation of catecholamine-synthesis enzymes, and increased epinephrine release were detected in MCF-7/Her2 cells. β2-AR expression induced by epinephrine and involvement of ERK signaling were validated. The data indicate that Her2 overexpression and excessive phosphorylation of ERK cause epinephrine autocrine release from breast cancer cells, resulting in up-regulation of β2-AR expression. The data also showed that catecholamine prominently stimulated Her2 mRNA expression and promoter activity. The activation and nuclear translocation of STAT3 triggered by isoproterenol were observed. Enhanced binding activities of STAT3 to the Her2 promoter after isoproterenol stimulation were verified. Using STAT3 shRNA and dominant negative STAT3 mutant, the role of STAT3 in isoproterenol-induced Her2 expression was further confirmed. The data support a model where β2-AR and Her2 comprise a positive feedback loop in human breast cancer cells.
引用
收藏
页码:351 / 362
页数:11
相关论文
共 50 条
  • [1] The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
    Shi, Ming
    Liu, Dan
    Duan, Huijun
    Qian, Lu
    Wang, Lina
    Niu, Lijia
    Zhang, Huipeng
    Yong, Zheng
    Gong, Zehui
    Song, Lun
    Yu, Ming
    Hu, Meiru
    Xia, Qing
    Shen, Beifen
    Guo, Ning
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 351 - 362
  • [2] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [3] IGF2 activation of HER2 receptor in HER2 positive breast cancer cell lines
    Helu, Xousaen M.
    De Leon, Daisy D.
    CANCER RESEARCH, 2012, 72
  • [4] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    Licai He
    Zhuanyun Du
    Xusheng Xiong
    Hua Ma
    Zhenfeng Zhu
    Hongwei Gao
    Jiawei Cao
    Tong Li
    Hongzhi Li
    Kaiyan Yang
    Guorong Chen
    Jennifer K. Richer
    Haihua Gu
    Scientific Reports, 7
  • [5] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    He, Licai
    Du, Zhuanyun
    Xiong, Xusheng
    Ma, Hua
    Zhu, Zhenfeng
    Gao, Hongwei
    Cao, Jiawei
    Li, Tong
    Li, Hongzhi
    Yang, Kaiyan
    Chen, Guorong
    Richer, Jennifer K.
    Gu, Haihua
    SCIENTIFIC REPORTS, 2017, 7
  • [6] HER2 Activating Mutations in Estrogen Receptor Positive Breast Cancer
    Murray E.M.
    Cherian M.A.
    Ma C.X.
    Bose R.
    Current Breast Cancer Reports, 2018, 10 (2) : 41 - 47
  • [7] IMMUNOTHERAPY FOR HER2 POSITIVE BREAST CANCER
    Vaidya, T. R.
    Ait-Oudhia, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S20
  • [8] Her2 positive breast cancer: practices
    Campone, Mario
    Berton-Rigaud, Dominique
    Bourbouloux, Emmanuelle
    Sophie, Sadot
    Zanetti, Alain
    Frenel, Jean-Sebastien
    BULLETIN DU CANCER, 2011, 98 (02) : 154 - 163
  • [9] TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
    Diaz-Rodriguez, E.
    Perez-Pena, J.
    Rios-Luci, C.
    Arribas, J.
    Ocana, A.
    Pandiella, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E11 - E11
  • [10] TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
    Diaz-Rodriguez, Elena
    Perez-Pena, Javier
    Rios-Luci, Carla
    Arribas, Joaquin
    Ocana, Alberto
    Pandiella, Atanasio
    CANCER LETTERS, 2019, 453 : 34 - 44